From: Role of ultrasound in predicting the molecular subtypes of invasive breast ductal carcinoma
No. (n = 160) | Percentage % | |
---|---|---|
Age (years) | ||
Mean ± SD | 52.69 ± 12.73 | |
Range | 23.0–86.0 | |
Size of lesion (cm) | ||
Mean ± SD | 3.10 ± 1.61 | |
Range | 1.0–9.0 | |
Echogenicity | ||
Isoechoic | 30 | 18.8 |
Heterogeneous | 20 | 12.5 |
Hypoechoic | 110 | 68.8 |
Shape | ||
Oval | 22 | 13.8 |
Rounded | 54 | 33.8 |
Irregular | 84 | 52.5 |
Margin | ||
Angular | 14 | 8.8 |
Spiculated | 77 | 48.1 |
Circumscribed | 18 | 11.3 |
Lobulated | 51 | 31.9 |
Orientation | ||
Parallel | 30 | 18.8 |
Non parallel | 130 | 81.3 |
Boundary | ||
Abrupt interface | 73 | 45.6 |
Echogenic halo | 87 | 54.4 |
Calcification | ||
Present | 62 | 38.8 |
Absent | 98 | 61.3 |
Posterior feature | ||
Posterior shadowing | 68 | 42.5 |
Posterior enhancement | 46 | 28.7 |
No posterior change | 46 | 28.7 |
Lymph node status | ||
Nodal metastasis | 71 | 44.4 |
No nodal metastasis | 89 | 55.6 |
Multiplicity | ||
Unifocal | 122 | 76.3 |
Multicentric or multifocal | 38 | 23.8 |
Grade of IDC | ||
Grade I | 15 | 9.4 |
Grade II | 95 | 59.4 |
Grade III | 50 | 31.3 |
Type | ||
Luminal A | 82 | 51.2 |
Luminal B | 26 | 16.3 |
Human epidermal growth factor receptor 2 | 26 | 16.3 |
Triple negative | 26 | 16.3 |